GlaxoSmithKline Expands into China with Nanjing MeiRui Pharma Acquisition
By Heather Cartwright
Pharma Deals Review: Vol 2010 Issue 10 (Table of Contents)
Published: 30 Dec-2010
DOI: 10.3833/pdr.v2010.i10.1415 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
GlaxoSmithKline (GSK) has acquired the Chinese pharmaceutical company Nanjing MeiRui Pharma for approximately US$70 M in cash, emphasising its focus on emerging markets...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018